The #1 Immunogenicity & Bioassay Event in the U.S.

Join leading FDA, industry, and academic experts at CHI’s 18th Annual Immunogenicity & Bioassay Summit, taking place October 19–22, 2026, in Alexandria, VA + virtually.

The 2026 event will feature comprehensive coverage of immunogenicity risk assessment, bioassay development, clinical strategies, and regulatory expectations, along with interactive discussions, expert-led training seminars and short courses, a dynamic exhibit and poster hall, and much more!

This premier summit provides the insights and high-value networking opportunities you need to move your programs forward. We look forward to welcoming you this October in Alexandria, VA!

Programs Bringing Together Top Industry, Academia & Regulatory Authorities

STREAMS

OCTOBER 19

OCTOBER 20-21

OCTOBER 21-22

IMMUNOGENICITY

Symposium
Immunology for Biotherapeutics

Immunogenicity Assessment & Clinical Relevance

Immunogenicity Prediction
& Control

BIOASSAYS

Biostatistics for Beginners

Statistical Methods for Bioassay Development and Analysis

Optimizing Bioassays for Biologics

Confirmed FDA Speakers Include:

Yow-Ming Wang, PhD

Yow-Ming Wang, PhD
CDER, FDA

Wojciech Jankowski, PhD

Wojciech Jankowski, PhD
CBER, FDA

Daniel Lagassé, PhD

Daniel Lagassé, PhD
CBER, FDA

Zuben Sauna, PhD

Zuben Sauna, PhD
CBER, FDA

VIEW PAST FDA SPEAKERS

VIEW ALL SPEAKERS

Network with Industry Titans from the FDA, Regeneron, AstraZeneca, Eli Lilly, Merck, Johnson & Johnson, Bristol Myers Squibb, Genentech, Moderna, Novo Nordisk, Bayer & More!

View Photos & Videos

Top Reasons to Attend

Engage directly with FDA and global regulatory leaders shaping expectations for immunogenicity risk assessment, ADA/NAb strategies, and bioanalytical validation, and gain clarity on evolving guidance impacting your development programs.
Gain practical insights from industry and academic experts advancing immunogenicity prediction, assay development, clinical immunogenicity assessment, and emerging therapeutic modalities, with real-world case studies and lessons learned.
Participate in interactive discussions and panels designed to address real-world scientific and regulatory challenges, allowing you to benchmark approaches, ask questions, and exchange perspectives with peers.

Explore a dynamic exhibit and poster hall featuring innovative technologies, solution providers, and cutting-edge research, and discover new tools and partners to support your work.
Expand your network with scientists and decision-makers working across biologics, cell and gene therapies, vaccines, and novel drug platforms, fostering meaningful connections that extend beyond the event.
Leave with actionable strategies and valuable connections — this premier meeting delivers the scientific depth, regulatory clarity, and peer network you need to confidently move your programs forward.

VIEW MORE TESTIMONIALS

Thank You to Our 2026 Corporate Sponsors